🇺🇸 FDA
Patent

US 11306132

HLA class II-restricted T cell receptors against mutated RAS

granted A61KA61K38/177A61K40/11

Quick answer

US patent 11306132 (HLA class II-restricted T cell receptors against mutated RAS) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/177, A61K40/11, A61K40/32, A61K40/4253